Gene Therapy for Atherosclerosis in Mice
Author Information
Author(s): Maohua Cao, Junaid A. Khan, Bum-Yong Kang, Jawahar L. Mehta, Paul L. Hermonat
Primary Institution: Central Arkansas Veterans Healthcare System
Hypothesis
The overexpression of two anti-inflammatory genes within a common signal transduction pathway may result in a beneficial gene cooperation and provide a stronger anti-inflammatory effect.
Conclusion
The study found that dual gene delivery of hIL-10 and hSTAT3 did not improve therapeutic efficacy compared to individual gene treatments.
Supporting Evidence
- Both IL-10 and STAT3 are known to inhibit atherosclerosis.
- The study used a high cholesterol diet to induce atherosclerosis in mice.
- Cholesterol levels were higher in dual gene-treated animals compared to those treated with hIL-10 alone.
Takeaway
Researchers tried giving two genes to mice to help with heart problems, but it didn't work better than just giving one gene.
Methodology
The study used LDLR knockout mice on a high cholesterol diet and delivered genes via adeno-associated virus injections, measuring various aortic parameters.
Limitations
The dual gene delivery did not show enhanced efficacy, possibly due to low co-expression of both genes in the same cells.
Participant Demographics
Male LDLR knockout mice weighing 16–20 grams.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website